Besides, the company offers PK or anti-drug antibodies (ADA) antibody preparation services, immunogenicity assays for multispecific antibodies, and serum concentration analysis, thus assisting ...
Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the ...
News Medical on MSN2d
New antibody reduces tumor growth in treatment-resistant breast, ovarian cancers: StudyImmunotherapy, or antibody treatment that activates the patients own immune system against cancer, is increasingly being ...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ...
Clinical Trials Arena on MSN18d
Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trialThe Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site in Australia.
Voyager Therapeutics (VYGR) announced positive topline data from the Company’s single ascending dose, SAD, trial of VY7523, an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback